SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharma gets approval from USFDA for Colesevelam Hydrochloride

17 Jul 2018 Evaluate

Glenmark Pharmaceuticals, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Colesevelam Hydrochloride for Oral Suspension, 1.875 grams/Packet and 3.75 grams/Packet, the generic version of Welchol for Oral Suspension, 1.875 grams/Packet and 3.75 grams/Packet, of Daiichi Sankyo Inc.

According to IQVIA sales data for the 12 month period ending May 2018, Welchol for Oral Suspension, 1.875 grams/Packet and 3.75 grams/Packet achieved annual sales of approximately $73.0 million.

The company’s current portfolio consists of 138 products authorized for distribution in the US marketplace and 62 ANDA’s pending approval with the USFDA.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

2377.90 4.15 (0.17%)
07-May-2026 12:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.40
Dr. Reddys Lab 1313.75
Cipla 1374.15
Zydus Lifesciences 942.60
Lupin 2474.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×